INDOCO REMEDIES
Back to Income Statement
|
INDOCO REMEDIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹-95 Cr | ₹-74 Cr | ₹98 Cr | ₹142 Cr | ₹155 Cr |
What is the latest Consolidated Net Profit of INDOCO REMEDIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹-95 Cr |
| Mar2025 | ₹-74 Cr |
| Mar2024 | ₹98 Cr |
| Mar2023 | ₹142 Cr |
| Mar2022 | ₹155 Cr |
How is Consolidated Net Profit of INDOCO REMEDIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹-95 Cr | Negative | |
| Mar2025 | ₹-74 Cr | Negative | |
| Mar2024 | ₹98 Cr | -30.78 | |
| Mar2023 | ₹142 Cr | -8.11 | |
| Mar2022 | ₹155 Cr | - | |
Compare Consolidated Net Profit of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,526.7 Cr | 13% | 22.5% | -11.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,791.0 Cr | 1.7% | -1.4% | 21.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,081.0 Cr | 2% | 10.3% | 49.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,351.0 Cr | -0.4% | -0.5% | 38.6% | Stock Analytics | |
| CIPLA | ₹114,163.0 Cr | -0.5% | -2.5% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.3 Cr | -1.2% | 0% | -7.1% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | 13% |
22.5% |
-11.7% |
| SENSEX | -1.2% |
-2.6% |
-5.2% |
You may also like the below Video Courses